# Zucara Therapeutics Inc. — Form D

Zucara Therapeutics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-06. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-03-06
- Form: D
- Accession: 0002059295-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 3
- Date of first sale: 2025-02-03
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-540044

## Issuer

- Name: Zucara Therapeutics Inc.
- CIK: 0002059295
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 1300-661 UNIVERSITY AVENUE, TORONTO, A6, M5G 0B7
- Phone: 4168593978

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Fred A Callori | Director | Toronto, A6 |
| Chris A Garabedian | Director | Toronto, A6 |
| Michael A Martin | Director | Toronto, A6 |
| Michael Midmer | Director | Toronto, A6 |
| Claude A Piche | Director | Toronto, A6 |
| Janet A Grove | Executive Officer | Toronto, A6 |
| Richard A Liggins | Executive Officer | Toronto, A6 |
| Michael Midmer | Executive Officer | Toronto, A6 |

## More

- [CIK 2059295 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2059295&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002059295-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.